Guideline-Concordant Antimicrobial Therapy for Healthcare-Associated Pneumonia: A Systematic Review and Meta-analysis
- 10 April 2013
- journal article
- review article
- Published by Springer Nature in Lung
- Vol. 191 (3) , 229-237
Abstract
The objective of this study was to perform a systematic review and meta-analysis of the impact of the 2005 American Thoracic Society/Infectious Diseases Society of America guideline-concordant antimicrobial therapy (GCAT) on mortality following healthcare-associated pneumonia (HCAP). We searched MEDLINE, EMBASE, BIOSIS, Cochrane CENTRAL Register of Controlled Trials, and Scopus for clinical trials and observational studies comparing GCAT to other treatment regimens in adults with HCAP. The primary outcome chosen was 30-day mortality from any cause. Secondary outcomes assessed length of hospital stay and time to clinical stability. Random effects models were used to generate pooled odds ratios (ORs) and weighed mean differences (WMDs). Heterogeneity was evaluated by the I2. A total of six studies were included in the analysis and involved 15,850 participants. Meta-analysis showed that GCAT was associated with increased 30-day mortality compared to non-GCAT (OR 1.80, 95 % confidence interval [CI] 1.26–2.7). There was no advantage in GCAT over non-GCAT in terms of hospital length of stay (WMD 1.18 days, 95 % CI −0.48 to 2.84) or time to clinical stability (WMD 0.17 days, 95 % CI −0.32 to 0.67). In hospitalized patients with HCAP, GCAT did not show survival benefit compared to non-GCAT. However, our results are limited by the cohort design of the selected studies and the degree of heterogeneity among them. Future trials are needed to identify risk factors for multidrug-resistant pathogens in HCAP patients who may benefit from broad-spectrum antimicrobial regimens.Keywords
This publication has 42 references indexed in Scilit:
- Clinical features of healthcare‐associated pneumonia (HCAP) in a Japanese community hospital: Comparisons among nursing home‐acquired pneumonia (NHAP), HCAP other than NHAP, and community‐acquired pneumoniaRespirology, 2011
- One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare SystemInternational Journal of Infectious Diseases, 2011
- Nursing home-acquired pneumonia: a 10 year single-centre experienceThorax, 2010
- Antibiotic prescription patterns in hospitalized patients with nursing home–acquired pneumoniaJournal of Hospital Medicine, 2010
- Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unitClinical Therapeutics, 2010
- Long-Term Survival after Hospitalization for Community-Acquired and Healthcare-Associated PneumoniaRespiration, 2009
- Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumoniaCurrent Opinion in Infectious Diseases, 2009
- Effect of Antibiotic Guidelines on Outcomes of Hospitalized Patients with Nursing Home–Acquired PneumoniaJournal of the American Geriatrics Society, 2009
- Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center ExperienceAntimicrobial Agents and Chemotherapy, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003